{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:44:32Z","timestamp":1759333472726},"reference-count":10,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T00:00:00Z","timestamp":1187827200000},"content-version":"vor","delay-in-days":5288,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Psychiatr Scand"],"published-print":{"date-parts":[[1993,3]]},"abstract":"<jats:p>Eleven chronic schizophrenic patients with abnormal skin pigmentation associated with neuroleptic treatment were withdrawn from chlorpromazine (CPZ), which was replaced by levomepromazine (<jats:italic>n<\/jats:italic>= 4), trifluoperazine (<jats:italic>n<\/jats:italic>= 1) or thioproperazine (<jats:italic>n<\/jats:italic>= 1) as the sole neuroleptic, by a combination of these phenothiazines (<jats:italic>n<\/jats:italic>= 4) or with haloperidol plus pipotiazine (<jats:italic>n<\/jats:italic>= 1). Seven patients showed complete resolution of abnormal skin pigmentation over a period of 1\u20135 years and 4 markedly improved over 2.0\u20132.6 years of follow\u2010up. Our observations suggest that neuroleptic\u2010induced abnormal skin pigmentation is (i) predominantly, if not exclusively, a side effect of CPZ and (ii) reversible, providing that CPZ is withdrawn and sufficient time is allowed to elapse.<\/jats:p>","DOI":"10.1111\/j.1600-0447.1993.tb03360.x","type":"journal-article","created":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T12:42:13Z","timestamp":1187872933000},"page":"223-224","source":"Crossref","is-referenced-by-count":10,"title":["Resolution of chlorpromazine\u2010induced cutaneous pigmentation following substitution with levomepromazine or other neuroleptics"],"prefix":"10.1111","volume":"87","author":[{"given":"D.","family":"Bloom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. X.","family":"Thavundayil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Lal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,8,23]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/070674378503000605","article-title":"Neuroleptic\u2010induced skin pigmentation in chronic hospitalized schizophrenic patients","volume":"30","author":"Ban TA.","year":"1985","journal-title":"Can J Psychiatry"},{"key":"e_1_2_1_3_2","first-page":"213","volume-title":"Clinical handbook of psychopharmacology","author":"Appleton WS.","year":"1970"},{"key":"e_1_2_1_4_2","first-page":"74","article-title":"Ocular and cutaneous effects of chronic phenothiazine therapy","volume":"37","author":"Bond WS.","year":"1980","journal-title":"Am J Hosp Pharmacy"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.123.3.351"},{"key":"e_1_2_1_6_2","first-page":"636","article-title":"Therapy of chlorpromazine melanosis","volume":"91","author":"Greiner AC.","year":"1964","journal-title":"Can Med Assoc J"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.138.12.1631"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1988.tb06416.x"},{"key":"e_1_2_1_9_2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1001\/jama.1965.03080040005001","article-title":"Pigmentation due to phenothiazines in high and prolonged dosage","volume":"1965","author":"Satanove A.","year":"1965","journal-title":"JAMA"},{"key":"e_1_2_1_10_2","first-page":"663","article-title":"Skin pigmentation and corneal and lens opacities with prolonged chlorpromazine therapy","volume":"90","author":"Greiner AC.","year":"1964","journal-title":"Can Med Assoc J"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(67)90023-9"}],"container-title":["Acta Psychiatrica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0447.1993.tb03360.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0447.1993.tb03360.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T11:57:15Z","timestamp":1698235035000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0447.1993.tb03360.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,3]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1993,3]]}},"alternative-id":["10.1111\/j.1600-0447.1993.tb03360.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0447.1993.tb03360.x","archive":["Portico"],"relation":{},"ISSN":["0001-690X","1600-0447"],"issn-type":[{"value":"0001-690X","type":"print"},{"value":"1600-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,3]]}}}